Targeted protein degradation: A promise for undruggable proteins

被引:153
作者
Samarasinghe, Kusal T. G. [1 ]
Crews, Craig M. [1 ,2 ,3 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[2] Yale Univ, Dept Mol, New Haven, CT 06511 USA
[3] Yale Univ, Dept Pharmacol, New Haven, CT 06511 USA
关键词
CHEMICALLY-INDUCED DEGRADATION; TYROSINE KINASE ACTIVATION; BETA-CATENIN; SELECTIVE DEGRADATION; CHIMERIC MOLECULES; PROTAC DESIGN; CANCER; RESISTANCE; INHIBITORS; UBIQUITINATION;
D O I
10.1016/j.chembiol.2021.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein homeostasis, or "proteostasis," is indispensable for a balanced, healthy environment within the cell. However, when natural proteostasis mechanisms are overwhelmed from excessive loads of dysregulated proteins, their accumulation can lead to disease initiation and progression. Recently, the induced degradation of such disease-causing proteins by heterobifunctional molecules, i.e., PROteolysis TArgeting Chimeras (PROTACs), is emerging as a potential therapeutic modality. In the 2 decades since the PROTAC concept was proposed, several additional Targeted Protein Degradation (TPD) strategies have also been explored to target previously undruggable proteins, such as transcription factors. In this review, we discuss the progress and evolution of the TPD field, the breadth of the proteins targeted by PROTACs and the biological effects of their degradation.
引用
收藏
页码:934 / 951
页数:18
相关论文
共 50 条
  • [1] Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors
    Dai, Mengyuan
    Radhakrishnan, Sridhar
    Li, Rui
    Tan, Ruirong
    Yan, Kuo
    Fan, Gang
    Liu, Miao
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [2] Advancement of targeted protein degradation strategies as therapeutics for undruggable disease targets
    Kannan, Mayuri P.
    Sreeraman, Sarojini
    Somala, Chaitanya S.
    Kushwah, Raja B. S.
    Mani, Saravanan K.
    Sundaram, Vickram
    Thirunavukarasou, Anand
    FUTURE MEDICINAL CHEMISTRY, 2023, 15 (10) : 867 - 883
  • [3] Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques
    Chen, Siyu
    Cui, Jingliang
    Chen, Haiyan
    Yu, Bo
    Long, Sihui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 262
  • [4] A novel cereblon modulator for targeted protein degradation
    Kim, Sung Ah
    Go, Ara
    Jo, Seung-Hyun
    Park, Sun Jun
    Jeon, Young Uk
    Kim, Ji Eun
    Lee, Heung Kyoung
    Park, Chi Hoon
    Lee, Chong-Ock
    Park, Sung Goo
    Kim, Pilho
    Park, Byoung Chul
    Cho, Sung Yun
    Kim, Sunhong
    Ha, Jae Du
    Kim, Jeong-Hoon
    Hwang, Jong Yeon
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 166 : 65 - 74
  • [5] Targeted protein degradation by PROTACs
    Neklesa, Taavi K.
    Winkler, James D.
    Crews, Craig M.
    PHARMACOLOGY & THERAPEUTICS, 2017, 174 : 138 - 144
  • [6] Development of targeted protein degradation therapeutics
    Chamberlain, Philip P.
    Hamann, Lawrence G.
    NATURE CHEMICAL BIOLOGY, 2019, 15 (10) : 937 - 944
  • [7] Targeted protein degradation for cancer therapy
    Hinterndorfer, Matthias
    Spiteri, Valentina A.
    Ciulli, Alessio
    Winter, Georg E.
    NATURE REVIEWS CANCER, 2025,
  • [8] Key Considerations in Targeted Protein Degradation Drug Discovery and Development
    Qin, Liena
    Dai, Han
    Wang, Junfeng
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [9] Protein-Targeted Degradation Agents Based on Natural Products
    Li, Yan
    Jia, Yi
    Wang, Xiaolin
    Shang, Hai
    Tian, Yu
    PHARMACEUTICALS, 2023, 16 (01)
  • [10] Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
    Naito, Mikihiko
    Ohoka, Nobumichi
    Shibata, Norihito
    Tsukumo, Yoshinori
    FRONTIERS IN CHEMISTRY, 2019, 7